Cancer Prevention Pharmaceuticals Submits EU Marketing Authorization Application for CPP-1X/sul for Treatment of Familial Adenomatous Polyposis

TUCSON, Arizona, June 18, 2020 – Cancer Prevention Pharmaceuticals, Inc. (CPP), a private biotech company developing novel therapeutics to prevent cancer and other diseases, announced today that it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for CPP-1X/sul for treatment of adults with familial adenomatous polyposis (FAP).Continue reading

Governor Ducey Announces Enhanced COVID-19 Action Plan

Governor Ducey, Dr. Christ, Maj. Gen McGuire provided an Arizona COVID-19 briefing on June 17, 2020. Governor Ducey reminded everyone of Three Key Messages for all Arizonans:

  1. You are safest at home.
  2. If you must go out, physically distance.
  3. If you can not, Wear A Mask.

Executive Order 40 includes that  “4.  Notwithstanding directives in Executive Order 2020-36, Stay Healthy, Return Smarter, Return Stronger, regarding A.R.S. § 26-307, a county, city or town may, based on conditions in its jurisdiction, adopt policies regarding the wearing of face coverings in public for the purpose of mitigating the spread of COVID-19. Any enforcement of such a policy shall focus first on educating and working to promote best practices to accomplish the goal of mitigation. An individual shall be notified of the provisions of this order or any policy adopted by a county, city or town and given an opportunity to comply prior to any enforcement action being taken.”

Continue reading

Mask Up Arizona

Wearing a mask when in a public setting, staying a safe distance away from other people, and following CDC recommendations relative disinfecting and personal hygiene can help slow the spread of COVID-19. This is key to improving health and to our economic recovery. 

Joan Koerber-Walker, president & CEO, AZBio  #MaskUpAZ #MaskUpArizona

Continue reading

C-Path’s Transplant Therapeutics Consortium Receives Acceptance of Letter of Intent for iBox Scoring System (Composite Biomarker Panel) as a Reasonably Likely Surrogate Endpoint

 

Biomarker aims to streamline the development of novel therapies intended to improve long-term outcomes for kidney transplant recipients.

 

TUCSON, Ariz., June 17, 2020 — Critical Path Institute (C-Path) announced today that its Transplant Therapeutics Consortium (TTC) has received a positive response to its Letter of Intent (LOI) from the U.S. Food and Drug Administration (FDA) detailing the decision to accept the Composite Biomarker Panel (iBox Scoring System) into the Center for Drug Evaluation and Research (CDER) Biomarker Qualification Program (BQP).Continue reading

New Report Examines Bioscience Industry’s Economic Impact in Arizona & Role in Global Pandemic

Chandler, Arizona – The Biotechnology Innovation Organization (BIO) released new data on the bioscience industry in the United States. The new report, The Bioscience Economy: Propelling Life-Saving Treatments, Supporting State & Local Communities, analyzes the bioscience industry’s economic footprint across the nation and in Arizona, the significant role of small- and mid-sized companies, and the industry’s response to the COVID-19 pandemic.Continue reading